A Study of RD06-04 in Patients With Active Autoimmune Diseases

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2027

Conditions

SLE (Systemic Lupus)SclerosisANCA Associated VasculitisIIMSSMSNMO Spectrum DisorderMG

Interventions

DRUG

RD06-04 cell infusion

CAR T Cells

Trial Locations (1)

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors

lead

Nanjing Bioheng Biotech Co., Ltd.

INDUSTRY